Clone to Clinic: Advancing your Gene Therapeutic from the Bench through Production

Clone to Clinic: Advancing your Gene Therapeutic from the Bench through Production

Wednesday, 4/29, 2-3pm

The promise and potential of gene therapy has been established with ample examples of success. However, the need for accurate cellular models in early discovery and efficacy testing, as well as process development and manufacturing partners are critically important to accelerate therapy to-market.

This webinar will walk you through MilliporeSigma’s end-to-end capabilities in gene therapy development. In the first portion, we will briefly cover CRISPR screening tools and cell line engineering partnership opportunities to develop accurate discovery and efficacy models. The second portion will then go through considerations when it comes to viral vector manufacturing, biosafety testing, potency and safety and commercial readiness in bringing your therapeutic to clinic.

Registration link:

https://primetime.bluejeans.com/a2m/register/tuuehcbv?mc_cid=eefc1a6894&mc_eid=bac0c001a1